{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:19:20Z","timestamp":1788193160108,"version":"build-2803163510"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To report the outcomes of patients with fovea-off tractional retinal detachment (TRD) from proliferative diabetic retinopathy (PDR) treated with serial anti-VEGF therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We reviewed the medical records of patients with fovea-off TRD from PDR treated with serial anti-VEGF therapy. Outcome measures included visual acuity, foveal reattachment, need for vitrectomy, number of intravitreal injections, and average interval between injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>12 eyes of 10 patients were included. 75% of eyes (n = 9) had foveal reattachment with anti-VEGF therapy alone. The average time from TRD diagnosis to foveal reattachment was 15 months. Patient who experienced foveal reattachment (n = 9) received an average of 7 injections with an average injection interval of 2.3 months. At presentation, mean logMAR VA was 1.79 (Snellen visual acuity equivalent 20\/1233). At 6 months, mean logMAR VA was 1.6 (20\/790), and at 12 months, mean logMAR VA was 1.4 (20\/466). At a last follow-up (mean 27.8 months), mean logMAR VA was to 1.36 (20\/453) among all patients and 1.01 (20\/204) among patients who had foveal reattachment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this cohort of eyes treated with intravitreal anti-VEGF for fovea-off TRD from PDR retinopathy, we observed visual and anatomic stability, and, in some cases, improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000005004","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:00:41Z","timestamp":1788192041000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of foveal-involving tractional retinal detachments from proliferative diabetic retinopathy with intravitreal anti-VEGF therapy"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-1389","authenticated-orcid":false,"given":"Nihaal","family":"Mehta","sequence":"first","affiliation":[{"name":"The Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Baker","family":"Hubbard","sequence":"additional","affiliation":[{"name":"The Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:00:41Z","timestamp":1788192041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000005004","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}